Classification
Product TypeIngredient
Product FormPowder (bulk vitamin ingredient) / finished-dose supplement forms
Industry PositionNutraceutical / Food Supplement Ingredient
Market
Vitamin B9 (folic acid) in Switzerland is primarily a regulated food-supplement nutrient ingredient used in measured-dose formats such as tablets, capsules, powders and liquids. Swiss food supplements are regulated as foods under food legislation, with safety and compliance ensured via operator self-supervision rather than routine pre-market authorization, except in specific cases (e.g., novel foods or unlisted health claims). Switzerland sets product-category requirements including maximum quantities for vitamins/minerals under the FDHA Ordinance on Food Supplements. A key market feature is the need to avoid medicinal positioning: dosage, presentation and claims can trigger a therapeutic-product classification with different oversight.
Market RoleImport-dependent consumer and formulation market (food supplements) with strict food-law compliance and classification controls
Domestic RoleUsed mainly to supplement diets via food supplements; compliance focuses on permitted substances, maximum levels, and permitted claims under Swiss food law
Specification
Primary VarietyFolic acid (vitamin B9)
Physical Attributes- Sold in concentrated, measured small-unit quantities (tablets/capsules/powder pouches/liquid ampoules or drops), consistent with Swiss food-supplement definitions.
Packaging- Pack formats are typically designed to deliver measured small-unit doses and to support compliant labeling and warnings for food supplements in Switzerland.
Supply Chain
Value Chain- Import by manufacturer/importer/distributor → self-supervision compliance checks (composition, dosage, labeling/claims) → distribution in Switzerland → enforcement via cantonal checks and spot checks at import/transit/export by FOCBS
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighMisclassification risk is a deal-breaker: if vitamin B9 products are presented with disease prevention/treatment intent or otherwise assessed as therapeutic products, they fall under therapeutic product legislation rather than food law, which can block import, marketing, and claims pathways intended for food supplements.Run a pre-market classification review focusing on dosage, labeling, purpose and advertising; align product positioning with Swiss food-supplement definitions and avoid medicinal indications unless pursuing the therapeutic-product route.
Regulatory Compliance MediumNoncompliance with Swiss maximum quantity limits and other conditions for vitamins/minerals under the FDHA Ordinance on Food Supplements can trigger enforcement actions and product withdrawal.Validate the daily portion and formulation against FoodSO maximum levels and any substance-specific conditions before import and sale.
Regulatory Compliance MediumHealth-claim noncompliance (claims not listed in Annex 14 FoodIO or lacking approval) can lead to corrective actions and reputational damage, especially for pregnancy-related messaging where claims are sensitive.Use only permitted Swiss health claims (Annex 14 FoodIO) under their conditions, or obtain approval for unlisted claims before use.
Border Control MediumImport spot checks by the Federal Office for Customs and Border Security and inland checks by cantonal authorities can identify labeling/claims/composition issues and cause delays or enforcement outcomes.Maintain a Switzerland-specific compliance dossier (label versions in an official language, claims rationale, composition/dose checks) and ensure tariff classification is correct in Tares.
FAQ
Do vitamin B9 (folic acid) food supplements need pre-market authorization or notification in Switzerland?Generally no. Switzerland treats food supplements as foods and they usually do not require authorization; instead, the manufacturer/importer/distributor is responsible for safety and compliance under self-supervision. Switzerland also does not require notification for food supplements, with specific exceptions such as novel foods, GMOs, or unlisted health claims.
What is the biggest regulatory pitfall for marketing vitamin B9 products in Switzerland?The main pitfall is being classified as a therapeutic product rather than a food supplement. If the product’s dosage, presentation, labeling, purpose, or advertising implies disease prevention or treatment, it can fall under therapeutic product legislation, changing the compliance route and potentially blocking the intended food-supplement market pathway.
Can you use health claims on vitamin B9 supplements in Switzerland?Yes, but only under strict conditions. Health claims can be used if they are listed in Annex 14 of the FDHA Ordinance on Information on Foodstuffs (FoodIO) and the conditions are met; claims not listed must be approved by the FSVO before use.